


Landkind announces GRAS status for biosynthesized salidroside

Landkind delivers cognitive function boost with GRAS-approved pure salidroside supplement

2022: The year of acceleration

Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside

Double Rainbow ramps up production of ancient natural painkiller

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

NutraCast: Utilizing synthetic biology to preserve medicinal plants

DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4
Double Rainbow Announces Membership with BioMADE

Big Pharma’s Green Ambitions
Kelai pens Double Rainbow pact to pair drug delivery and biosynthesis tech

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics
